Polen public
[search 0]
More

Download the App!

show episodes
 
1
1Komma5Grad

1
1Komma5Grad

RTL Radio Lëtzebuerg

Unsubscribe
Unsubscribe
Monthly
 
Héichwaasser zu Lëtzebuerg, Polen di schmëlzen, Bränn am Süde vun Europa, Temperature vu bal 50 Grad Celsius a Kanada. Och ouni 6. Rapport vum Weltklimarot ass kloer: d Wiederextremer huelen zou. Virun allem sinn sech awer d'Experten eens a sécher, dass et eng mënschegemaachte Kris ass. Sou akut, dass d'Wuert Klimawandel net méi passt, awer Klima-Urgence. Am Podcast 1Komma5Grad diskutéieren d' Caroline Mart an de Pierre Weimerskirch iwwert eng vun de gréissten Erausfuerderunge fir d' Politik ...
 
Tyréns är ett av Sveriges ledande konsultföretag inom samhällsbyggnad. I samspel med kunder och partners skapar vi hållbara lösningar inom stadsutveckling och infrastruktur. Vi har 3 000 medarbetare och verksamhet i Sverige, England, Estland, Litauen och Polen. Tyréns är stiftelseägt och vår ägandeform gör det möjligt för oss att satsa målmedvetet på forskning och utveckling inom samhällsbyggnadsområdet. Vi drivs av nyfikenhet och har ett nära samarbete med universitet och högskolor.
 
In this podcast series, Paul O'Connor, Netwealth's Head of Investment Management & Research, picks the brains of key wealth management professionals to uncover unique insights on the investment areas they are most passionate about. Together they explore potential opportunities, challenges and considerations in the market while also sharing fascinating stories and lessons from their experience. We hope you enjoy the unique perspectives.
 
https://linktr.ee/TempleOfBleh Podcast about Metal. Numbered Episodes - Northerners rambling about metal Lettered Episodes* - Interviews Neither number or letter - One-off/Documentary *HORR episodes deal with History of Roadrunner Records, the pod's current documentary project.
 
Break the Norm is a podcast designed to create conversation around what it means to have an unconventional career and life on the path to fulfillment. It's an amazing time to pursue your big dreams and create a career path on your own terms. Each week, I'll be giving real life applicable tips & strategies to help you to start breaking the norm right away. Break the Norm so you can have the life & job you want and deserve!
 
Loading …
show series
 
Becton Dickinson’s CEO Tom Polen lays out the company’s plan for growth that’s building off a stunning sequence of acquisitions over the past two years that has the company loaded with tech – including digital and robotics tools – to drive its future growth. Polen also shares his tragic introduction to medtech and shares how that experiences influe…
 
Robert Cohen has his eyes on the future of orthopedic surgery, but he brings a wealth of knowledge about its past as well. In this interview, Cohen reviews his long history in orthopedic surgery, dating back to his studies in college. Over his career, Cohen has had a role in materials, 3D-printing, and began working with MAKO Surgical several years…
 
In this week’s episode, CEO Kevin Sayer takes a few minutes to share Dexcom’s vision for the future OUTSIDE of diabetes. What does this mean for people with diabetes and others who could benefit from the powerful Dexcom G7? We also bring in a very popular interview from our MedtronicTalks podcast series – Skip Kiil, president of cranial and spinal …
 
Pristine Surgical CEO Bryan Lord spent his career advising and investing in medical device companies, so he didn’t immediately see how a “conspicuous outsider” like himself would be the right person to serve as CEO of start-up Pristine Surgical. But he immediately recognized the satisfaction in leading the company’s work to create first-of-its-kind…
 
In this episode, your diligent team of DeviceTalkers - Executive Editor Chris Newmarker, Pharma Editor Brian Buntz, Managing Editor Jim Hammerand, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley and DeviceTalks Editorial Director Tom Salemi – assembled to review our Top 10 events, trends and newsmakers.We’ve got some highs – robots, dia…
 
In this episode, we’ll speak with ReCor Medical’s CEO Andy Weiss and Helen Reeve-Stoffer, PHD, the company’s vice president of clinical affairs. The pair joined the renal denervation company in 2013, before disappointing results of a Medtronic-trial temporarily cratered the entire space. But now through careful clinical testing ReCor Medical is cli…
 
In this interview, Andy Pierce, group president of MedSurg and Neurotechnology, details how the company strives to create products that nurses and hospital staff find essential to everyday patient care. The kind of attention to detail that can drive a nurse to hug a Neptune waste management system. “This is what we live for at Stryker,” Pierce says…
 
In this episode, Celine Martin, company group chairman, Cardiovascular & Specialty Solutions Group, offers insights from her career at Johnson & Johnson. What are the four variables you need to consider to thrive in a global company. Martin also shares insights on cardiac ablation, neurovascular, and where the company is headed following the acquis…
 
Unfortunately, we missed Diabetes Awareness Month by a few days, but we get great insights on this dreaded disease from two players in the space. Krista Sugerman, vice president, global marketing & communications at Medtronic’s diabetes business, shares how diabetes has impacted people close to her and why the company is keeping focused on how a di…
 
In this episode of StrykerTalks, Robbie Robinson, president of Stryker’s Spine division, touts the strength of a business build out with sizable acquisitions in recent years, including K2M. Does Robinson see any gaps in Stryker’s offerings? Where can other Stryker businesses help Stryker Spine reach new heights in the coming years? Thanks to Tegra …
 
This episode of IntuitiveTalks is taken from the keynote interview Intuitive CEO Gary Guthart gave at DeviceTalks West. In this conversation Guthart will provide additional details of Intuitive’s move into endoscopic robotics including the ION robot. He'll give his assessment of the growing competition in surgical robotics and what it means for Int…
 
In this episode, we talk with medtech vet Matt Franklin who left the industry. – sort of – to help lead Akili, developer of EndeavoRx, the first prescription treatment delivered through a video game. The game treats kids with ADHD, but the company has bigger plans. Chris Newmarker, executive editor of life sciences, returns with his newsmakers incl…
 
In this episode, Kate Stewart, vice president and general manager of ENT, explains how her first introduction into medical devices came as a patient. Stewart’s Stryker career began in her native Australia but quickly went global. She now leads the ENT business in Minneapolis. Stewart identifies the key leadership quality she’s come to appreciate, p…
 
In this episode, we’ll talk with Keith Grossman, who brought his long, successful track record as a medtech CEO to what he sees as a truly disruptive neurostimulation company. We’ll talk with Grossman about his decision to join medtech even though unlike some of his counterparts he enjoyed organic chemistry (aka, the Medtech career creator) in coll…
 
In this podcast we’ll talk with Chris Hartman, president, epilepsy, LivaNova, about how the company is developing new tools to use the vagus nerve to limit the impact of epilepsy.We’ll also hear from one of our DeviceTalks West Panels about how workforce shortages are impacting medical device development. The panelists are Nilesh Patel, M.D. Vice P…
 
In this week’s episode, we’ll visit with CL Tian, co-founder and CEO of Phiex Technologies, Medtech Innovator’s 2022 Grand Prize winner chosen by attendees at this week’s AdvaMed conference in Boston. Tian details the pending problems facing the medtech industry due to concerns about current sterilization practices and shares how Phiex could help a…
 
Just a short visit today. Paul Grand of the Medtech Innovator introduces us the five finalists of his start-up program. They’ll compete for the top spot at AdvaMed’s meeting next week. in Boston. Remember to join us at DeviceTalks West THIS week. Register at DeviceTalks.com.By DeviceTalks by MassDevice
 
In this episode we’ll talk with Kathryn Rieger, PhD, senior director, human factors and user research at Intuitive, about how the surgical robotics leader is working with surgeons to understand how to make its surgical systems easier to use or, for lack of a better word, intuitive. Where should buttons go. What does the blue blinking light mean? An…
 
Editorial Director Tom Salemi provides a sneak peek (listen?) into next week’s DeviceTalks West conference which will be held Oct. 19-20 at the Santa Clara Convention Center. Tom will run through some of the highlights of the agenda which can be viewed at west.devicetalks.com. We also include snippets of past interviews of two keynotes – Gary Gutha…
 
With the end of most central bank's quantitative easing programs and the normalisation of cash rates, is now the time to buy bonds again and to increase duration positioning in portfolios? Since central banks commenced explicitly targeting inflation in the mid 1980’s, cash rates and bond yields have fallen creating an environment where fixed intere…
 
In this episode, we’ll first hear from Swarna Alcorn, business unit vice president, Olympus America, about that company’s long held – and growing -position in respiratory tools. We’ll weight the value between reusable and single-use bronchoscopes as well as the dire need for more awareness of lung cancer. Then we’ll connect with Rebecca Whitney, gl…
 
In this week’s episode, we’ll talk with leaders from Zimmer Biomet and Vicarious Surgical about the new partners they’ve entered into with national hospital companies in a bid to further their digital and robotics surgery offerings. Guests include Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet, and Adam Sachs, c…
 
This episode of the DeviceTalks Weekly podcast features a panel discussion I led at Medmarc’s Annual Broker meeting. There are enormous insights on how investors and start-up executives see the opportunities and challenging facing the sector today. Below, you can see time stamps for each of the major topics we covered. We suggest sitting back and l…
 
The medical device industry obviously isn’t immune to the challenges posed by a shaky supply chain. But OEM leaders like Boston Scientific need to work doubly hard to ensure they have the supplies needed to provide devices for patient care. In this episode, we’ll talk with Brad Sorenson, executive vice president, Global Operations, and Paudie O’Con…
 
Nearly 700,000 people die from heart disease, that’s one out of every five deaths, a startling number that could be curtailed with better predictive tools. In this episode, we’ll talk with two medical device companies employing new analytical tools to get a clearer picture of heart health. We’ll first connect with Campbell Rogers, MD, executive vic…
 
In this episode, Eileen Buckley, vice president, corporate responsibility, unpacks how Stryker is following its environmental, social and governance strategies to encourage its employees, suppliers and even customers to meet increased demands for greater healthcare access and a smaller environmental impact. In a time where employees look to work wi…
 
In this episode, two senior leaders from Medtronic’s Cardiovascular Diagnostics & Services group share the group’s vision of “turning data into the right therapy.” Sanjiv Arora, vice president of business development and strategy, and Leo Rapallini, vice president of research & development, explain how trail-blazing technologies like the LINQ famil…
 
In this episode, two newer players to the surgical robotics space explain how they’re planning to grab their appropriate slice of the growing market. First, we’ll talk with Kurt Azarbarzin, CEO of EndoQuest Robotics, which is developing the world’s first endoluminal robotic surgical system that can access the body through the mouth or anus. In our …
 
In this episode, Mike Panos, president of the trauma and extremities division, explains how Stryker built a powerhouse in their shoulder and foot and ankle businesses through internal development and the acquisition of Wright Medical. The purchase brought Stryker a new line of products and a virtual planning tool called Blueprint. We also explore t…
 
As the world moves to net zero emissions, natural resources companies will be crucial in facilitating the production and development of renewable, and low carbon energy sources. In this episode, Tim Gerrard, Portfolio Manager at Janus Henderson, shares his investment strategy for net zero emissions and provides some examples of ‘traditional’ resour…
 
In this episode of the DeviceTalks Weekly Podcast, we collect three very different perspectives on what it takes to find jobs/employees in this current labor market. First, we connect with Joe McClung, president of Floodgate Medical, an executive search firm focused on the medical device industry, for an overview of the current market and some tips…
 
In this replay of our most recent MedtronicTalks episode, Dr. Laura Mauri shares the career path that started with an early interest in medicine brought, at least partly, by her mother’s cancer diagnosis. Mauri directed that interest in caring for patients – and an innate ability to keep cool under pressure – to become an interventional cardiologis…
 
In this replay of the popular MedtronicTalks podcast episode, Greg Smith brought decades of supply chain experience with him when he joined Medtronic last year during the throes of pandemic-induced pressures on supply chain. Over that time, Smith has been working with company leaders and outside suppliers to mitigate the challenges being wrought by…
 
In this episode, Tom O’Brien, Ethicon’s worldwide president of endomechanical, gives a detailed lesson on the design of its Echelon 3000 surgical stapler, from recognizing the huge problem of surgical complications and identifying how to build a stapler that’s more suited to ALL surgeons. The Echelon 3000 is designed with 39% greater jaw aperture a…
 
In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Bost…
 
The resilience of Australia’s economy is about to be tested with strong commodity prices providing some insulation as the RBA becomes increasingly hawkish. WaveStone Capital’s Portfolio Manager Catherine Allfrey joins the show to discusses the divergent paths for resources, financials and industrials and the opportunities available to investors as …
 
In this episode of IntuitiveTalks, Jonathan Conta, vice president of product management, shares Intuitive’s vision for its da Vinci SP system, a single-port system. Rather than using four arms outside the body that require multiple ports, da Vinci SP can create triangulation inside the body. Intuitive has secured broad approval for the system in Ko…
 
In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific e…
 
In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific. Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control esse…
 
In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend…
 
This week listeners will get to hear how Stryker is incorporating Vocera, Gauss and other tech into its DRE strategy. We’ll get a visit from fellow podcaster Keith Figlioli of LRV Health to talk about Oracle’s acquisition of Cerner. And Chris “WorkLord” Newmarker brings a star-studded Newmarker’s Newsmakers feature Smith & Nephew, GE Healthcare, Et…
 
2022 has finally seen a surge in inflation across developed countries and the big question now is whether this is structural or more transitory. In this episode, we chat with Brett Lewthwaite, Senior Managing Director, Chief Investment Officer, and Global Head of Fixed Income at Macquarie Asset Management, to discuss supply shocks, the changing rol…
 
In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against …
 
Parenthood changes everyone, but Mark Paul’s life took a drastically different turn the moment his oldest child was born. Paul discovered he had a passion for the OR and patient treatment, a realization that convinced him to switch careers to the medical device industry. Today, Paul leads Stryker’s neurovascular business which, he says, contains th…
 
In this episode the MassDevice editorial team will break down all the action at DeviceTalks Boston. You’ll also hear from keynote speaker Eric Benjamin, executive vice president of innovation, strategy and digital products, at the company. To read MassDevice’s coverage of DeviceTalks Boston go here. https://www.massdevice.com/tag/devicetalks-boston…
 
First, a quick recap of DeviceTalks Boston. Then, a MedtronicTalks Podcast Replay, in which Austin L. Chiang, MD, explains why he brought his sizable social media following to Medtronic, where he serves as chief medical officer of the Gastrointestinal business. Chiang says his decision is directly tied to his excitement about Medtronic’s growing su…
 
Investor concerns about inflation and rising interest rates are likely exacerbating selloffs and volatility in certain segments of the Australian share market. In this episode, Dushko Bajic, Head of Australian Equities Growth at First Sentier Investors unpacks some of the risks ahead and shares some potential investment opportunities for investors.…
 
Loading …

Quick Reference Guide

Copyright 2023 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login